Mon, July 25, 2022

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Decreased Target to $4 on, Jul 25th, 2022

Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Decreased Target from $6 to $4 on, Jul 25th, 2022.

Raghuram, nor any peers, have made any analyst calls on ADMA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30